Northern Minerals & Exploration Ltd largest revenue segment is Point-of-care Testing, Low-dose Interferon Alpha Therapeutics and Synthetic RNA-driven preventative Medicine, at a revenue of 20,729 in the most earnings release.For geography, United States is the primary market for Northern Minerals & Exploration Ltd, at a revenue of 20,729.